Factors Requiring Midazolam in Addition to Systemic Opioids to Control Dyspnea in Cancer Patients at the End of Life-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors Requiring Midazolam in Addition to Systemic Opioids to Control Dyspnea in Cancer Patients at the End of Life

Published:2023 Issue:4 Volume:18 Page:247-252
ISSN:1880-5302
Container-title:Palliative Care Research
language:en
Short-container-title:Palliat Care Res

Author:

Okuda Yuka¹,Kuriyama Toshiyuki¹,Tsukiyama Yoshi¹,Matsuda Yoshinobu²,Yamaguchi Takashi³,Mori Masanori⁴,Shimokawa Toshio⁵,Kawamata Tomoyuki¹

Affiliation:

1. Division of Palliative Care, Department of Anesthesiology, School of Medicine, Wakayama Medical University

2. Department of Psychosomatic Internal Medicine, Kinki-Chuo Chest Medical Center

3. Department of Palliative Medicine, Kobe University Graduate School of Medicine

4. Division of Palliative and Supportive Care, Seirei Mikatahara General Hospital

5. Clinical Study Support Center, Wakayama Medical University

Publisher

Japanese Society for Palliative Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jspm/18/4/18_23-00026/_pdf

Reference12 articles.

1. 1） Chan K, Doris MW Tse, et al. Dyspnea and other respiratory symptoms in palliative care. Oxford Textbook of Palliative Medicine, 5th ed, Cherny NI (eds). Oxford University Press, New York, 2015; 421–29.

2. 2） Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage 2010; 39: 680–90.

3. 3） Hui D, dos Santos R, Chisholm GB, et al. Symptom expression in the last seven days of life among cancer patients admitted to acute palliative care units. J Pain Symptom Manage 2015; 50: 488–94.

4. 4）日本緩和医療学会，緩和医療ガイドライン委員会編．がん患者の呼吸器症状の緩和に関するガイドライン2016年版．金原出版，東京，2016; 66.

5. 5） Mori M, Matsunuma R, Suzuki K, et al. Palliative care physicians’ practice in the titration of parenteral opioids for dyspnea in terminally ill cancer patients: a Nationwide survey. J Pain Symptom Manage 2019; 58: e2–5.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3